Back
Soligenix Vs. Lixte Biotechnology Holdings Industry Stock Comparison
Sell
29
SNGX
Soligenix
Last Price:
3.67
Seasonality Move:
118.42%
Sell
19
LIXT
Lixte Biotechnology Holdings
Last Price:
1.64
Seasonality Move:
0.45%
Sell
29
Soligenix (SNGX)
is a Sell
Is Soligenix a Buy, Sell or Hold?
- The current Soligenix [SNGX] share price is $3.70. The Score for SNGX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SNGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
- The current Lixte Biotechnology Holdings [LIXT] share price is $1.65. The Score for LIXT is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $1.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.
SNGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 49.73 | Sell |
| Chaikin Money Flow: | 15448 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.54 - 3.86) | Sell |
| Bollinger Bands (100): | (2.88 - 5.14) | Sell |
LIXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 43.74 | Sell |
| Chaikin Money Flow: | -13735 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.62 - 2) | Sell |
| Bollinger Bands (100): | (1.77 - 2.27) | Sell |
SNGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.58 | Buy |
| 20-day SMA: | 3.68 | Buy |
| 50-day SMA: | 3.78 | Sell |
| 200-day SMA: | 6.06 | Sell |
| 8-day EMA: | 3.63 | Buy |
| 20-day EMA: | 3.68 | Buy |
| 50-day EMA: | 3.82 | Sell |
| 200-day EMA: | 7.47 | Sell |
LIXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.74 | Sell |
| 20-day SMA: | 1.82 | Sell |
| 50-day SMA: | 1.86 | Sell |
| 200-day SMA: | 2.34 | Sell |
| 8-day EMA: | 1.73 | Sell |
| 20-day EMA: | 1.79 | Sell |
| 50-day EMA: | 1.87 | Sell |
| 200-day EMA: | 2.36 | Sell |
Soligenix Earnings Growth & SNGX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.35 per share.
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Soligenix Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lixte Biotechnology Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||